Therapeutic

In this section you will find information products, including market insight and company profiles, covering major therapeutic sectors, including CNS, Obesity, Oncology, Vaccines and Women's Health.

Stay up-to-date with new products added to this category »

Title	Publication Date	Price
Competitor Analysis: Biologic and Immune Therapy of S. aureus Infections	March 2010	£180
Neuroprotection Drugs, Markets and Companies	March 2010	£2970
Antiviral Therapeutics Technologies, Markets and Companies	March 2010	£2115
Personalized Medicine Scientific & Commercial Aspects	March 2010	£2640
Pain Therapeutics Drugs, Markets and Companies	March 2010	£2310
Cell Therapy Technologies, Markets and Companies	March 2010	£3300
Neuropathic Pain: Emerging Drugs and Current Treatment Practices	February 2010	£2999
Competitor Analysis: BlyS, BAFF & APRIL Antagonists	February 2010	£90
Oncology Pipeline Database: 1-Year Subscription	Ongoing	£1615
Bladder Cancer Therapeutics	February 2010	£2610
Therapies for Depressive and Anxiety Disorders	February 2010	£3205
Rheumatoid Arthritis Therapeutics	February 2010	£2610
Myocardial Infarction Therapy Area Pipeline Report	January 2010	£985
Myasthenia Gravis Therapy Area Pipeline Report	January 2010	£985
Muscle Pain Therapy Area Pipeline Report	January 2010	£985
Nasal congestion Therapy Area Pipeline Report	January 2010	£985
Nausea and Vomiting Therapy Area Pipeline Report	January 2010	£985
Neuropathy Therapy Area Pipeline Report	January 2010	£985
Neuralgia Therapy Area Pipeline Report	January 2010	£985
Multiple Sclerosis Therapy Area Pipeline Report	January 2010	£985
Migraine Therapy Area Pipeline Report	January 2010	£985
Malaria Therapy Area Pipeline Report	January 2010	£985
Kidney Stones Therapy Area Pipeline Report	January 2010	£985
Macular Degeneration Therapy Area Pipeline Report	January 2010	£985
Memory Impairment Therapy Area Pipeline Report	January 2010	£985
Non-Small-Cell Lung Cancer or Lung Cancer or Small Cell Lung Cancer Therapy Area Pipeline Report	January 2010	£985
Menopausal Symptoms Therapy Area Pipeline Report	January 2010	£985
Ischemia Therapy Area Pipeline Report	January 2010	£985
Labor and Delivery Therapy Area Pipeline Report	January 2010	£985
Ocular Inflammation Therapy Area Pipeline Report	January 2010	£985
Parkinson Disease Therapy Area Pipeline Report	January 2010	£985
Panic Disorder Therapy Area Pipeline Report	January 2010	£985
Pancreatic Cancer Therapy Area Pipeline Report	January 2010	£985
Peptic Ulcer or Gastric Ulcer or Duodenal Ulcer Therapy Area Pipeline Report	January 2010	£985
Peripheral Vascular Disease Therapy Area Pipeline Report	January 2010	£985
Postmenopausal Osteoporosis Therapy Area Pipeline Report	January 2010	£985
Poisoning Therapy Area Pipeline Report	January 2010	£985
Pneumonia Therapy Area Pipeline Report	January 2010	£985
Paget's Disease Therapy Area Pipeline Report	January 2010	£985
Overactive Bladder Therapy Area Pipeline Report	January 2010	£985
Onychomycosis Therapy Area Pipeline Report	January 2010	£985
Ocular Hypertension Therapy Area Pipeline Report	January 2010	£985
Obsessive-Compulsive Disorder Therapy Area Pipeline Report	January 2010	£985
Irritable Bowel Syndrome Therapy Area Pipeline Report	January 2010	£985
Opium Addiction Therapy Area Pipeline Report	January 2010	£985
Ovarian Cancer Therapy Area Pipeline Report	January 2010	£985
Osteoporosis Therapy Area Pipeline Report	January 2010	£985
Osteoarthritis Therapy Area Pipeline Report	January 2010	£985
Obesity Therapy Area Pipeline Report	January 2010	£985
Indigestion Therapy Area Pipeline Report	January 2010	£985
Gastroesophageal Reflux Disease Therapy Area Pipeline Report	January 2010	£985
Fungal Infections or Candidiasis Therapy Area Pipeline Report	January 2010	£985
Flatulence Therapy Area Pipeline Report	January 2010	£985
Gaucher's Disease Therapy Area Pipeline Report	January 2010	£985
Gingivitis or Periodontitis Therapy Area Pipeline Report	January 2010	£985
Growth Hormone Deficiency Therapy Area Pipeline Report	January 2010	£985
Gout Therapy Area Pipeline Report	January 2010	£985
Glaucoma Therapy Area Pipeline Report	January 2010	£985
Fever Therapy Area Pipeline Report	January 2010	£985
Female Sexual Dysfunction Therapy Area Pipeline Report	January 2010	£985
Ear Infections Therapy Area Pipeline Report	January 2010	£985
Dysmenorrhea Therapy Area Pipeline Report	January 2010	£985
Dry Eye Syndrome Therapy Area Pipeline Report	January 2010	£985
Edema Therapy Area Pipeline Report	January 2010	£985
Endometriosis Therapy Area Pipeline Report	January 2010	£985
Eye Infections Therapy Area Pipeline Report	January 2010	£985
Erectile Dysfunction Therapy Area Pipeline Report	January 2010	£985
Epilepsy Therapy Area Pipeline Report	January 2010	£985
Headache Therapy Area Pipeline Report	January 2010	£985
Helminthic Infestations Therapy Area Pipeline Report	January 2010	£985
Hypotension Therapy Area Pipeline Report	January 2010	£985
Hypogonadism Therapy Area Pipeline Report	January 2010	£985
Hypocalcemia Therapy Area Pipeline Report	January 2010	£985
Prostate Cancer Therapy Area Pipeline Report	January 2010	£985
Infertility Therapy Area Pipeline Report	January 2010	£985
Insomnia or Sleep Disorders Therapy Area Pipeline Report	January 2010	£985
Influenza Therapy Area Pipeline Report	January 2010	£985
Inflammatory Bowel Disease Therapy Area Pipeline Report	January 2010	£985
Hyperphosphatemia Therapy Area Pipeline Report	January 2010	£985
Hypercholesterolemia Therapy Area Pipeline Report	January 2010	£985
Hepatitis Therapy Area Pipeline Report	January 2010	£985
Hepatitis C Therapy Area Pipeline Report	January 2010	£985
Hemorrhoids Therapy Area Pipeline Report	January 2010	£985
Herpes Simplex Virus Infection Therapy Area Pipeline Report	January 2010	£985
Hormone Replacement Therapy Therapy Area Pipeline Report	January 2010	£985
Hypercalcemia Therapy Area Pipeline Report	January 2010	£985
Huntington Disease Therapy Area Pipeline Report	January 2010	£985
Intermittent Claudication Therapy Area Pipeline Report	January 2010	£985
Restenosis Therapy Area Pipeline Report	January 2010	£985
Inflammation Therapy Area Pipeline Report	January 2010	£985
Hyperlipemia Therapy Area Pipeline Report	January 2010	£985
Hemorrhage Therapy Area Pipeline Report	January 2010	£985
Kidney Cancer Therapy Area Pipeline Report	January 2010	£985
Liver Cancer Therapy Area Pipeline Report	January 2010	£985
Multiple Myeloma Therapy Area Pipeline Report	January 2010	£985
Melanoma or Skin Cancer Therapy Area Pipeline Report	January 2010	£985
Lymphoma Therapy Area Pipeline Report	January 2010	£985
Hemophilia or Blood Coagulation Disorders Therapy Area Pipeline Report	January 2010	£985
Head and Neck Cancer Therapy Area Pipeline Report	January 2010	£985
Brain Tumor Therapy Area Pipeline Report	January 2010	£985
Bladder Cancer Therapy Area Pipeline Report	January 2010	£985
Autoimmune Diseases Therapy Area Pipeline Report	January 2010	£985
Breast Cancer Therapy Area Pipeline Report	January 2010	£985
Colorectal Cancer or Colon Cancer Therapy Area Pipeline Report	January 2010	£985
Gastrointestinal (Stomach) Cancer Therapy Area Pipeline Report	January 2010	£985
Electrolyte Deficiencies Therapy Area Pipeline Report	January 2010	£985
Dyslipidemia Therapy Area Pipeline Report	January 2010	£985
Myelodysplastic Syndrome Therapy Area Pipeline Report	January 2010	£985
Non-Hodgkin Lymphoma Therapy Area Pipeline Report	January 2010	£985
RNA Interference Therapy in Oncology Drug Pipeline Update 2010	January 2010	£895
Peptides in Oncology Drug Pipeline Update 2010	January 2010	£1345
Gene Therapy in Oncology Drug Pipeline Update 2010	January 2010	£1345
Immunotherapy in Oncology Drug Pipeline Update 2010	January 2010	£2195
Kinase Therapeutics Pipeline Assessment and Commercial Prospects	January 2010	£2995
Influenza Vaccines Pipeline Analysis and Market Forecasts to 2016	January 2010	£1320
Brain Tumor Drug Pipeline Analysis and Market Forecasts to 2016	January 2010	£1320
Anti-Obesity Drug Pipeline Analysis and Market Forecasts to 2016	January 2010	£1320
Cytokine Therapy in Oncology Drug Pipeline Update 2010	January 2010	£895
Cellular Therapy in Oncology Drug Pipeline Update 2010	January 2010	£895
Thromboembolism Therapy Area Pipeline Report	January 2010	£985
Thrombocytopenia or Idiopathic Thrombocytopenic Purpura Therapy Area Pipeline Report	January 2010	£985
Rheumatoid Arthritis Therapy Area Pipeline Report	January 2010	£985
Transplant Rejection or Transplantation Therapy Area Pipeline Report	January 2010	£985
Central Nervous System Pain Therapy Area Pipeline Report	January 2010	£985
Analytical Tool - Peptides in Oncology	January 2010	£2780
Infections Bacterial Infections Therapy Area Pipeline Report	January 2010	£985
Arthritis Therapy Area Pipeline Report	January 2010	£985
Anemia Therapy Area Pipeline Report	January 2010	£985
Staphylococcal Infections Therapy Area Pipeline Report	January 2010	£985
Smoking Cessation Therapy Area Pipeline Report	January 2010	£985
Skin and Soft Tissue Infections Therapy Area Pipeline Report	January 2010	£985
Stroke_Cardiovascular and Circulatory System Therapy Area Pipeline Report	January 2010	£985
Stroke_Central Nervous System Therapy Area Pipeline Report	January 2010	£985
Thrombosis Therapy Area Pipeline Report	January 2010	£985
Throat Infection Therapy Area Pipeline Report	January 2010	£985
Tetanus Therapy Area Pipeline Report	January 2010	£985
Skin Infections or Dermatosis or Skin Itching Therapy Area Pipeline Report	January 2010	£985
Sepsis Therapy Area Pipeline Report	January 2010	£985
Pulmonary Hypertension Therapy Area Pipeline Report	January 2010	£985
Pulmonary Fibrosis Therapy Area Pipeline Report	January 2010	£985
Psychotic Disorders Therapy Area Pipeline Report	January 2010	£985
Respiratory Tract Infections Therapy Area Pipeline Report	January 2010	£985
Diphtheria Therapy Area Pipeline Report	January 2010	£985
Seborrheic Dermatitis Therapy Area Pipeline Report	January 2010	£985
Schizophrenia Therapy Area Pipeline Report	January 2010	£985
Scabies Therapy Area Pipeline Report	January 2010	£985
Tinea Pedis (Athlete's Foot) Therapy Area Pipeline Report	January 2010	£985
Tuberculosis Therapy Area Pipeline Report	January 2010	£985
Vitamin Deficiency Therapy Area Pipeline Report	January 2010	£985
Viral Infections Therapy Area Pipeline Report	January 2010	£985
Vertigo Therapy Area Pipeline Report	January 2010	£985
Wilson Disease Therapy Area Pipeline Report	January 2010	£985
Wounds or Wound Dressing Therapy Area Pipeline Report	January 2010	£985
Allergy Therapy Area Pipeline Report	January 2010	£985
Acute Lymphoblastic Leukemia or Leukemia or Chronic Lymphocytic Leukemia or Chronic Myelogenous Leukemia or Acute Myelogenous Leukemia or Hairy Cell Leukemia Therapy Area Pipeline Report	January 2010	£985
Wrinkles Therapy Area Pipeline Report	January 2010	£985
Varicose Veins Therapy Area Pipeline Report	January 2010	£985
Vaginal Infections Therapy Area Pipeline Report	January 2010	£985
Type II Diabetes Therapy Area Pipeline Report	January 2010	£985
Type I Diabetes Therapy Area Pipeline Report	January 2010	£985
Turner's Syndrome Therapy Area Pipeline Report	January 2010	£985
Ulcerative Colitis Therapy Area Pipeline Report	January 2010	£985
Ulcers Therapy Area Pipeline Report	January 2010	£985
Urinary Tract Infections Therapy Area Pipeline Report	January 2010	£985
Urinary Incontinence Therapy Area Pipeline Report	January 2010	£985
Psoriasis Therapy Area Pipeline Report	January 2010	£985
Hepatitis B Therapy Area Pipeline Report	January 2010	£985
Angina Therapy Area Pipeline Report	January 2010	£985
Amyotrophic Lateral Sclerosis Therapy Area Pipeline Report	January 2010	£985
Alzheimer Disease Therapy Area Pipeline Report	January 2010	£985
Alopecia (Hair Loss) Therapy Area Pipeline Report	January 2010	£985
Antidote Therapy Area Pipeline Report	January 2010	£985
Apoptosis in Oncology Pipeline Update 2010	January 2010	£1345
Atrial Fibrillation Therapy Area Pipeline Report	January 2010	£985
Atherosclerosis or Coronary Artery Disease Therapy Area Pipeline Report	January 2010	£985
Asthma Therapy Area Pipeline Report	January 2010	£985
Diarrhea Therapy Area Pipeline Report	January 2010	£985
Alcoholism Therapy Area Pipeline Report	January 2010	£985
Acute Intestinal Amebiasis Therapy Area Pipeline Report	January 2010	£985
Analytical Tool: Apoptosis Promise or deception?	January 2010	£2780
Analytical Tool - Competitive Outlook on Anti-Angiogenesis and Vascular Targeting in Oncology	January 2010	£2780
Antibodies in Oncology Pipeline Update 2010	January 2010	£1345
Vascular Targeting and Anti-angiogenesis in Oncology Pipeline Update 2010	January 2010	£1345
AIDS Therapy Area Pipeline Report	January 2010	£985
Abnormal Uterine Bleeding Therapy Area Pipeline Report	January 2010	£985
Acute Coronary Syndromes Therapy Area Pipeline Report	January 2010	£985
Acne Therapy Area Pipeline Report	January 2010	£985
Acidity Therapy Area Pipeline Report	January 2010	£985
Attention Deficit Disorder with Hyperactivity Therapy Area Pipeline Report	January 2010	£985
Anxiety Therapy Area Pipeline Report	January 2010	£985
Dementia Therapy Area Pipeline Report	January 2010	£985
Cystic Fibrosis Therapy Area Pipeline Report	January 2010	£985
Cough Therapy Area Pipeline Report	January 2010	£985
Contraception Therapy Area Pipeline Report	January 2010	£985
Analytical Tool: Protein Kinase Inhibitors in Oncology	January 2010	£3180
Depression Therapy Area Pipeline Report	January 2010	£985
Diabetic Retinopathy Therapy Area Pipeline Report	January 2010	£985
Diabetic Neuropathy Therapy Area Pipeline Report	January 2010	£985
Diabetic Nephropathy Therapy Area Pipeline Report	January 2010	£985
Constipation Therapy Area Pipeline Report	January 2010	£985
Dental Pain Therapy Area Pipeline Report	January 2010	£985
Benign Prostatic Hyperplasia Therapy Area Pipeline Report	January 2010	£985
Conjunctivitis Therapy Area Pipeline Report	January 2010	£985
Bronchitis Therapy Area Pipeline Report	January 2010	£985
Bipolar Disorder Therapy Area Pipeline Report	January 2010	£985
Burns Therapy Area Pipeline Report	January 2010	£985
Bronchospasm Therapy Area Pipeline Report	January 2010	£985
Congestive Heart Failure Therapy Area Pipeline Report	January 2010	£985
Chronic Obstructive Pulmonary Disease Therapy Area Pipeline Report	January 2010	£985
Caries Therapy Area Pipeline Report	January 2010	£985
Cachexia Therapy Area Pipeline Report	January 2010	£985
The Future of Global Vaccines Market Forecasts to 2015	December 2009	£2310
The Future of Orphan Diseases Therapeutics Market Forecasts to 2015	December 2009	£2310
The Future of Metabolic Disorder Therapeutics Market Forecasts to 2015	December 2009	£2310
The Future of Cardiovascular Diseases Therapeutics Market Forecasts to 2015	December 2009	£2310
The Future of HIV Therapeutics Market Forecasts to 2015	December 2009	£2310
Neuropathic Pain Drug Pipeline Analysis and Market Forecasts to 2015	December 2009	£1320
Epilepsy Drug Pipeline Analysis and Market Forecasts to 2015	December 2009	£1320
The Future of Respiratory Diseases Therapeutics Market Forecasts to 2015	December 2009	£2310
Obesity, Weight Loss and Diet Management Markets Pharmaceutical, Surgical and Dietary Approaches	December 2009	£2310
The Future of Oncology Therapeutics Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis	December 2009	£2310
Hepatitis B Vaccines Pipeline Analysis and Market Forecasts to 2015	December 2009	£1320
The Future of Autoimmune Diseases Therapeutics Market Forecasts to 2015	December 2009	£2310
Global Vaccines Market	December 2009	£3965
Apoptotic Therapeutics in Oncology - Where to Commercialize?	November 2009	£2195
Anti-Obesity Drugs Trends & Opportunities Worldwide	November 2009	£1980
Systemic Fungal Infection Therapeutics Market - Australia	November 2009	£3965
Hepatitis C Virus and Therapeutics A Global Update of Market Trends & Opportunities	November 2009	£1980
Innovations In Epigenetics Advances in Technologies, Diagnostics & Therapeutics	November 2009	£3835
Systemic Fungal Infection Therapeutics Market- Taiwan	November 2009	£3965
Fat Replacers US Market Trends	November 2009	£1980
Therapeutic Apheresis A US Market Review	November 2009	£1980
Systemic Fungal Infection Therapeutics Market - China	November 2009	£3965
Multiple Myeloma Therapeutics US Market Trends & Analysis	November 2009	£1980
Human Vaccines Global Market Opportunities	November 2009	£1980
Systemic Fungal Infection Therapeutics Market - Singapore	November 2009	£3965
Systemic Fungal Infection Therapeutics Market - India	November 2009	£3965
World Market for Addiction Disorders, 2009 - 2016 The Future Therapies for Substance Dependence and Impulse Control	October 2009	£1495
Systemic Fungal Infection Therapeutics Market - South Korea	October 2009	£3965
Systemic Fungal Infection Therapeutics Research - Malaysia	October 2009	£3965
Japanese Market for Women's Health Devices 2009	October 2009	£4950
Monoclonal Antibody Therapeutics 2009-2024	August 2009	£1499
Competitor Analysis: Targeted Therapy of Hepatitis C	August 2009	£450
Insulin Delivery Systems Market Analysis (2008-2012)	August 2009	£925
Analyzing Edible Vaccines	July 2009	£1500
Antihormonal Therapies Market Forecast	July 2009	£10040
Commercial Insight: Antihormonal Cancer Therapies	July 2009	£10040
Stakeholder Opinions: Skin and soft tissue infections	July 2009	£2510
Pipeline and Commercial Insight: Obesity - the $11 billion market that never was	July 2009	£10040
Delivering RNAi-Based Therapeutics & Diagnostics Challenges & Opportunities	July 2009	£945
ASCO 2009: Significant Developments in Context	July 2009	£595
Lung Cancer Therapeutics	July 2009	£2610
U.S. CRO Markets: Key Therapeutic Areas	July 2009	£3965
Autoimmune Disease Therapeutics	July 2009	£2610
Western European Market for Compression Therapy	June 2009	£3965
Monoclonal Antibodies in Cancer Therapy 2009-2024	May 2009	£1499
World Vaccines Market 2008-2013 Future Forecast, Critical Trends and Developments	April 2009	£335
Pipeline Insight: Benign Prostatic Hyperplasia - Novel therapeutics and reformulations will drive market growth	April 2009	£3965
Therapeutics for Memory and Cognition Disorders	April 2009	£3205
The Autoimmune Outlook to 2013 Competitive landscape, pipeline analysis and growth opportunities	April 2009	£2025
Research Report in Vaccine Industry	April 2009	£200
ScientiaVision Product Pinpoint: The New Vaccines	March 2009	£1980
Direct-To-Consumer Genetic Testing Business Prospects in the United States	March 2009	£2475
Arrhythmiasis Therapy Area Pipeline Report	March 2009	£520
Women's Health: Worldwide Prescription Drug Markets, 4th Edition	February 2009	£1980
U.S. Market for Women's Health Devices 2009	January 2009	£4950
Delivering New Biopharmaceutical Therapies Challenges & Opportunities	January 2009	£945
Nosocomial Infections: Market Impact on Diagnostics and Therapeutics: (MRSA, HAP, C. diff and other Hospital Acquired Infections)	January 2009	£2310
Oncology Roadmap: Brand Spending Benchmarks and Market Forecast to 2013	January 2009	£6600
U.S. Market for Women's Health Devices 2009	January 2009	£4950
Protein Therapeutics Markets (Antithrobins, Cytokines, Growth Hormones, Hematopoietics, Insulin, Monoclonal Antibodies, Plasma Proteins, Vaccines, and Other Treatments)	December 2008	£2310
Stem Cell-Based Therapeutic Delivery Challenges & Opportunities	December 2008	£945
Trends & Strategies in Weight Management Ten Key Case Studies	November 2008	£256
Emerging Cancer Vaccines: Market Forecasts, New Developments and Pipeline Analysis 3rd Edition	November 2008	£2640
Stakeholder Opinions: Bladder Cancer New drugs needed to challenge ineffective 20 year old drugs	November 2008	£1320
Global Anti-Addiction Market, 2008-2023, the	November 2008	£1499
Immunotherapies and Vaccines for Cancer and Infectious Diseases	October 2008	£2475
Oncology Market Leaders Analyses and Outlook, Market Report 2008 - 2023	October 2008	£1499
Women's Reproductive Disorders Therapeutics 2008-2018	September 2008	£1499
Global Vaccines Market 2008-2023, The	August 2008	£1499
Therapeutic Monoclonal Antibodies Report 2008-2023	July 2008	£1499
China Vaccine Market Report 2007-2009	July 2008	£890
Oncology Market Forecast to 2013	July 2008	£10765
Pipeline Insight: Breast Cancer Recent approvals increase pressure on pipeline candidates	April 2008	£3965
Pipeline Insight: Non-Small Cell Lung Cancer Pipeline set to offer only modest improvements	April 2008	£3965
Pipeline Insight: Nosocomial Vaccines Minefield or Goldmine?	April 2008	£3965
The Deployment of Antibody Technologies for the Advancement of Cancer Therapeutics	April 2008	£2015
The Future of Targeted Therapeutics Key Technologies, New Therapy Area Applications and Leading Players	March 2008	£1995
Vaccines	March 2008	£600
Management of Acute Brain and Spinal Cord Injury Series: Neurological Disease and Therapy	March 2008	£130
Standard and Speciality Medical Beds and Therapeutic Surfaces Worldwide	February 2008	£1320
Adolescent Rheumatology	February 2008	£85
Pathology & Therapeutics for Pharmacists 3rd Edition	February 2008	£45
Sleep and Breathing in Children A Developmental Approach Developmental Changes in Sleep Patterns	February 2008	£115
Textbook of Surgical Oncology	November 2007	£125
The Gastrointestinal Market Outlook To 2012	October 2007	£1495
Mayo Clinic Medical Neurosciences	October 2007	£40
Interventional Neuroradiology	October 2007	£115
The Premenstrual Disorders: PMS and PMDD	October 2007	£110
Vitrification in Assisted Reproduction: A User's Manual and Trouble-shooting Guide	October 2007	£125
Decoding Big Pharma's R&D Strategy in Oncology	September 2007	£1755
Targeted Therapies in Oncology	September 2007	£105
Reperfusion Therapy for Acute Myocardial Infarction	September 2007	£130
Atlas of Endometriosis 5th edition	September 2007	£75
Atlas of Urogynecological Endoscopy	September 2007	£110
Advanced Drug Formulation Design to Optimize Therapeutic Outcomes	September 2007	£115
The World Market for Gynaecology 2007-2017	September 2007	£3200
Obesity Drug Discoveries: what the future holds	August 2007	£1425
Obesity Drug Discoveries: what the future holds + Obesity Tracker	August 2007	£1425
Immunomodulators Therapeutic Needs, Pipelines & Prospects	August 2007	£1495
Contemporary Targeted Therapies in Rheumatology	August 2007	£95
Cardiovascular Pharmaceutical Market Trends, 2007 to 2010 Key market forecasts and growth opportunities	August 2007	£895
Anti-Obesity Treatments 2007-2012 - A blockbuster target market	July 2007	£1799
Female Sexual Dysfunction Prescription Drug Pipeline Overview 2007	July 2007	£1320
Cell Therapy Markets	July 2007	£2245
Future Product Opportunities in Cosmeceuticals Innovation in food and drinks with beauty benefits	July 2007	£995
Thrombus and Stroke	July 2007	£85
Global Vaccine Market Outlook (2007-2010)	June 2007	£1055
Contraception Today: A Pocketbook for Primary Care Practitioners 6th edition	June 2007	£50
Obstetric Evidence-Based Guidelines	June 2007	£95
Prenatal Assessment in Multiple Pregnancy	June 2007	£100
Maternal-Fetal Medicine Evidence-Based Guidelines	June 2007	£95
Gastrointestinal Oncology Evidence and Analysis	June 2007	£115
Analytical Tool - Targeted Therapeutics: Non-Small Cell Lung Cancer Non-Small Cell Lung Cancer	May 2007	£2780
Women's Health Market Outlook to 2011	May 2007	£1495
Recurrent Pregnancy Loss	May 2007	£75
Targeted Therapies in Oncology	May 2007	£100
Obstructive Sleep Apnea Pathophysiology, Comorbidities, and Consequences	May 2007	£145
Ventilatory Support for Chronic Respiratory Failure Series: Lung Biology in Health and Disease	May 2007	£400
Cardiac Resynchronization Therapy	May 2007	£145
Bipolar Disorder 2nd edition	May 2007	£600
Drug-Induced Liver Disease 2nd edition	May 2007	£145
Complicatons in Peripheral Vascular Interventions	May 2007	£90
Monoclonal Antibodies, Vaccines and Other Immunologic Cancer Treatments World Market	May 2007	£1320
Carotid Atherosclerotic Disease: Pathologic Basis for Treatment	April 2007	£125
The Ischemic Penumbra	April 2007	£130
Thrombus and Stroke	April 2007	£85
Medical Problems in Women over 70 When Normative Treatment Plans do not Apply	April 2007	£55
Boston IVF Handbook of Infertility	March 2007	£45
Epigenomics Emerging Opportunities in Biomarkers, Diagnostics and Therapeutics	March 2007	£3205
Anti-Infectives World Market, 2nd. Ed., Vol. I	March 2007	£1980
Global Markets for Antifungal Agents	March 2007	£3205
Vaccines: The World Market	February 2007	£2640
Global Market and Future Outlook for Neurodegenerative Disorder Therapies 2007, The	January 2007	£1485
Vaccines Market Insight Products, Pipelines & Market Outlook	January 2007	£1095
Monoclonal Antibodies 2007 Competitive Landscape & Pipeline Insight	January 2007	£1485
World Market for Psychotherapeutic Drugs, The	January 2007	£2310
Triple Analysis: Apoptosis Agents, Antibodies and Vaccines in Oncology	December 2006	£3090
Global Protein Therapeutics Market, The Market Dynamics and Pipeline Analysis	December 2006	£1980
Therapeutic Radiopharmaceuticals Markets Sector Snapshot	December 2006	£330
Stakeholder Opinions: Hormonal Contraceptives New directions in a competitive market	November 2006	£1325
Anti Addiction Therapies, 2006-2011- The Pharmaceutical Industry's Next Viagra?	October 2006	£1499
Commercial Insight: Neuropathic Pain A Plethora of Patient Segmentation and Product Differentiation Opportunities	July 2006	£5575
The Future of Monoclonal Antibodies Therapeutics Innovation in antibody engineering, key growth strategies and forecasts to 2011	July 2006	£1495
Global Vaccine Market Forecast to 2012	June 2006	£1320
Protein Therapeutics Market; The The Science and Business of a Growing Sector	June 2006	£2575
Enzyme Inhibitors with Broad Therapeutic Applications	June 2006	£2885
Lymphoma A Therapeutic & Competitive Insight	May 2006	£1745
An Evaluation of Products and Technologies for Molecular Diagnostics within Oncology	May 2006	£3140
U.S. Market for Gastrointestinal Pharmaceuticals Sector Snapshot	March 2006	£330
Chinese Markets for Vaccines	March 2006	£1985
Strategic Outlook on Protein Kinase Inhibitors in Oncology	February 2006	£1745
Cell Culture Vessels Trends 2006	February 2006	£1540
Antiageing and Life Enhancement Pharmacotherapeutics	January 2006	£795
Drug Targets for Breast Cancer	January 2006	£1095
Stem Cell Therapies and Regenerative Medicine Current Applications and Future Possibilities	December 2005	£2885
Global Image Dermatology Drug Market, 2005-2012, The High-Growth Opportunities in Aesthetic Medicine	November 2005	£795
Aromatherapy Science A Guide for Healthcare Professionals	November 2005	£45
Market for Organ and Tissue Transplantation and Alternatives; The	October 2005	£2885
Handbook of Biogeneric Therapeutic Proteins Regulatory, Manufacturing, Testing, and Patent Issues	August 2005	£130
Directory of Therapeutic Enzymes	August 2005	£92
New Therapeutics and Diagnostics for Women’s Disorders	May 2005	£2885
Radiation-based Therapy and Therapeutic Imaging	May 2005	£2885
Chronotherapeutics	September 2003	£75
5-HT7 antagonists Novel molecules for the unmet migraine prophylaxis market	March 2003	£330
Stem Cell Therapeutics Markets	February 2002	£1650

Therapeutic

Therapeutic

RSS Feed

Bookmark this Category